{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T14:00:33Z","timestamp":1778680833262,"version":"3.51.4"},"reference-count":18,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,8]],"date-time":"2022-06-08T00:00:00Z","timestamp":1654646400000},"content-version":"vor","delay-in-days":2290,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001381","name":"National Research Foundation Singapore","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001381","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001348","name":"Agency for Science, Technology, and Research, Singapore","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001348","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100004726","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004726","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","exphem.org","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Hematology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/j.exphem.2015.12.002","type":"journal-article","created":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T00:33:44Z","timestamp":1450398824000},"page":"189-193.e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Inhibition of isoprenylcysteine carboxylmethyltransferase augments BCR-ABL1 tyrosine kinase inhibition-induced apoptosis in chronic myeloid leukemia"],"prefix":"10.1016","volume":"44","author":[{"given":"Wen Tian","family":"Sun","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bee Ling","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kartini","family":"Asari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralph M.","family":"Bunte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick J.","family":"Casey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles","family":"Chuah","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exphem.2015.12.002_bib1","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1182\/blood.V96.10.3343","article-title":"The molecular biology of chronic myeloid leukemia","volume":"96","author":"Deininger","year":"2000","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.12.002_bib2","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1365-2141.2007.06578.x","article-title":"Dual inhibition of ras and bcr-abl signalling pathways in chronic myeloid leukaemia: A phase I\/II study in patients in complete haematological remission","volume":"137","author":"Pavlu","year":"2007","journal-title":"Br J Haematol"},{"key":"10.1016\/j.exphem.2015.12.002_bib3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1182\/asheducation-2008.1.427","article-title":"Novel agents in CML therapy: Tyrosine kinase inhibitors and beyond","author":"Melo","year":"2008","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.exphem.2015.12.002_bib4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev.bi.65.070196.001325","article-title":"Protein prenylation: Molecular mechanisms and functional consequences","volume":"65","author":"Zhang","year":"1996","journal-title":"Annu Rev Biochem"},{"key":"10.1016\/j.exphem.2015.12.002_bib5","doi-asserted-by":"crossref","first-page":"7346","DOI":"10.1074\/jbc.M311602200","article-title":"Carboxyl methylation of Ras regulates membrane targeting and effector engagement","volume":"279","author":"Chiu","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2015.12.002_bib6","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1073\/pnas.0408107102","article-title":"A small-molecule inhibitor of isoprenylcysteine carboxyl methyltransferase with antitumor activity in cancer cells","volume":"102","author":"Winter-Vann","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2015.12.002_bib7","doi-asserted-by":"crossref","first-page":"18678","DOI":"10.1074\/jbc.M801855200","article-title":"A small molecule inhibitor of isoprenylcysteine carboxymethyltransferase induces autophagic cell death in PC3 prostate cancer cells","volume":"283","author":"Wang","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2015.12.002_bib8","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.1038\/onc.2010.247","article-title":"Inhibition of isoprenylcysteine carboxylmethyltransferase induces autophagic-dependent apoptosis and impairs tumor growth","volume":"29","author":"Wang","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/j.exphem.2015.12.002_bib9","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1182\/blood-2007-06-094060","article-title":"Inactivating Icmt ameliorates K-RAS-induced myeloproliferative disease","volume":"112","author":"Wahlstrom","year":"2008","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.12.002_bib10","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.4161\/cbt.29692","article-title":"An improved isoprenylcysteine carboxylmethyltransferase inhibitor induces cancer cell death and attenuates tumor growth in\u00a0vivo","volume":"15","author":"Lau","year":"2014","journal-title":"Cancer Biol Ther"},{"key":"10.1016\/j.exphem.2015.12.002_bib11","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1182\/blood-2003-04-1271","article-title":"BCR\/ABL kinase inhibition by imatinib mesylate enhances MAP kinase activity in chronic myelogenous leukemia CD34+ cells","volume":"103","author":"Chu","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.exphem.2015.12.002_bib12","doi-asserted-by":"crossref","first-page":"11011","DOI":"10.1073\/pnas.0504952102","article-title":"Inhibition of drug-resistant mutants of ABL, KIT, and EGF receptor kinases","volume":"102","author":"Carter","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.exphem.2015.12.002_bib13","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.hoc.2004.03.003","article-title":"Animal models of chronic myelogenous leukemia","volume":"18","author":"Ilaria","year":"2004","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.exphem.2015.12.002_bib14","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1002\/cncr.21590","article-title":"Pilot study of lonafarnib, a farnesyl transferase inhibitor, in patients with chronic myeloid leukemia in the chronic or accelerated phase that is resistant or refractory to imatinib therapy","volume":"106","author":"Borthakur","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/j.exphem.2015.12.002_bib15","doi-asserted-by":"crossref","first-page":"14459","DOI":"10.1074\/jbc.272.22.14459","article-title":"K- and N-Ras are geranylgeranylated in cells treated with farnesyl protein transferase inhibitors","volume":"272","author":"Whyte","year":"1997","journal-title":"J Biol Chem"},{"key":"10.1016\/j.exphem.2015.12.002_bib16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1172\/JCI200418829","article-title":"Inactivation of Icmt inhibits transformation by oncogenic K-Ras and B-Raf","volume":"113","author":"Bergo","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/j.exphem.2015.12.002_bib17","doi-asserted-by":"crossref","first-page":"6838","DOI":"10.1021\/jm1002843","article-title":"Amino derivatives of indole as potent inhibitors of isoprenylcysteine carboxyl methyltransferase","volume":"53","author":"Go","year":"2010","journal-title":"J Med Chem"},{"key":"10.1016\/j.exphem.2015.12.002_bib18","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ejmech.2013.02.007","article-title":"Functionalized indoleamines as potent, drug-like inhibitors of isoprenylcysteine carboxyl methyltransferase (Icmt)","volume":"63","author":"Ramanujulu","year":"2013","journal-title":"Eur J Med Chem"}],"container-title":["Experimental Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X15007997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301472X15007997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,11]],"date-time":"2022-06-11T05:12:41Z","timestamp":1654924361000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301472X15007997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S0301472X15007997"],"URL":"https:\/\/doi.org\/10.1016\/j.exphem.2015.12.002","relation":{},"ISSN":["0301-472X"],"issn-type":[{"value":"0301-472X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Inhibition of isoprenylcysteine carboxylmethyltransferase augments BCR-ABL1 tyrosine kinase inhibition-induced apoptosis in chronic myeloid leukemia","name":"articletitle","label":"Article Title"},{"value":"Experimental Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exphem.2015.12.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 ISEH - International Society for Experimental Hematology. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}